Screening of Latent Tuberculous Infection (LTBI) before starting anti-tumor necrosis factor therapy in patients with psoriasis: A primer for clinical dermatologist
Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI a...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Książka |
| Wydane: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
| Hasła przedmiotowe: | |
| Dostęp online: | Connect to this object online. |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
| Streszczenie: | Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI and anti-TNF-α agents and provides working guidelines for screening of LTBI and its management before prescribing anti-TNF-α therapy in patients with psoriasis. |
|---|---|
| Deskrypcja: | 0019-5154 1998-3611 10.4103/ijd.IJD_649_16 |